Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2001, p. 263-266, Vol. 45, No. 1
Center for the Study of Emerging and
Re-emerging Pathogens,1 Division of Infectious
Diseases, Department of Internal
Medicine,2 and Department of
Microbiology and Molecular Genetics,3 The
University of Texas Medical School at Houston, Houston, Texas 77030
Received 6 July 2000/Returned for modification 24 August
2000/Accepted 25 October 2000
The complete sequence (1,479 nucleotides) of msrC, part
of which was recently reported by others using a different strain, was
determined. This gene was found in 233 of 233 isolates of Enterococcus faecium but in none of 265 other enterococci.
Disruption of msrC was associated with a two- to eightfold
decrease in MICs of erythromycin azithromycin, tylosin, and
quinupristin, suggesting that it may explain in part the apparent
greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. This endogenous,
species-specific gene of E. faecium is 53% identical to
msr(A), suggesting that it may be a remote progenitor of
the acquired macrolide resistance gene found in some isolates of staphylococci.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.1.263-266.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Disruption of an Enterococcus faecium Species-Specific
Gene, a Homologue of Acquired Macrolide Resistance Genes of
Staphylococci, Is Associated with an Increase in Macrolide
Susceptibility
*
Corresponding author. Mailing address: Center for the
Study of Emerging and Re-emerging Pathogens, University of Texas
Medical School
Houston, 6431 Fannin, 1.728 JFB, Houston, TX
77030. Phone: (713) 500-6767. Fax: (713) 500-6766. E-mail:
infdis{at}heart.med.uth.tmc.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |